Clinical Trials Directory

Trials / Completed

CompletedNCT03999086

Thromboelastography-Guided Fluid Management in Spinal Surgery

Thromboelastography-guided Fluid Management in Spinal Surgery: A Prospective Analysis

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years – 89 Years
Healthy volunteers
Not accepted

Summary

The Researchers are trying to evaluate whether using a blood test called thromboelastogram (TEG) to manage patients undergoing multi-level spinal fusion surgery will reduce complications after surgery compared with the standard practices.

Detailed description

Multi-level instrumented spinal fusions represent an important treatment modality for degenerative scoliosis and sagittal malalignment. These surgeries remain a significant physiologic burden with high blood loss and long operative times. Thromboelastography provides a quantitative measure for blood product transfusion surrounding procedures. We aim to utilize thromboelastography to guide transfusions for multi-level spinal instrumentation. This two-arm, randomized, non-blinded prospective analysis will clarify reduced transfusion requirements for TEG-arm compared to non-TEG arm. We will also evaluate postoperative outcomes at the 1 year time-point.

Conditions

Interventions

TypeNameDescription
PROCEDUREInterventionWe will utilize thromboelastography to discern when to transfuse blood products in the setting of multi-level spinal fusion
OTHERControl GroupLaboratory analysis to guide transfusion

Timeline

Start date
2018-01-12
Primary completion
2019-11-08
Completion
2019-11-08
First posted
2019-06-26
Last updated
2021-02-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03999086. Inclusion in this directory is not an endorsement.